Vivaglobin and injection site swelling Patient Reports February 11, 2012

Vivaglobin Side Effects Report #6005353-9
Vivaglobin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2008. Female patient, 15 years of age, was diagnosed with selective polysaccharide antibody deficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: complex regional pain syndrome , injection site swelling, movement disorder . Vivaglobin dosage: 60 ML Q1W SC. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #6039521-7
Vivaglobin side effect was reported by a Physician from UNITED STATES on Dec 30, 2008. Female patient, 15 years of age, weighting 119.0 lb, was diagnosed with immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: complex regional pain syndrome , injection site swelling, movement disorder , skin discolouration. Vivaglobin dosage: 60 ML Q1W SC. During the same period patient was treated with ZANTAC. Patient recovered.

Vivaglobin Side Effects Report #6125895-5
Vivaglobin side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, child 9 years of age, weighting 50.00 lb, was diagnosed with hypogammaglobulinaemia and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: infusion site extravasation, infusion site pain, injection site swelling. Vivaglobin dosage: 16 ML Q1W SC, SC. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #5594543-5
Vivaglobin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 02, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: contusion, erysipelas, injection site erythema, injection site rash, injection site swelling, migraine , rash erythematous, skin reaction. Vivaglobin dosage: 114 MG DAILY SC; 114 ML Q1W SC. During the same period patient was treated with PHYLOCONTIN, QVAR, SEREVENT, ATROVENT, ALBUTEROL, QUININE SULPHATE, PREGABALIN. Patient recovered.


Vivaglobin Side Effects Report #5625210-7
Vivaglobin side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: erysipelas, infusion related reaction, infusion site bruising, infusion site rash, injection site erythema, injection site swelling, local reaction, migraine , rash erythematous. Vivaglobin dosage: 114 ML Q1W; SC. During the same period patient was treated with PHYLLOCONTIN, QVAR, SEREVENT, ATROVENT, ALBUTEROL. Patient recovered.

Vivaglobin Side Effects Report #6059546-5
Vivaglobin side effect was reported by a Physician from UNITED STATES on Jan 14, 2009. Female patient, 15 years of age, weighting 119.0 lb, was diagnosed with antibody test negative and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: complex regional pain syndrome , injection site swelling, monoplegia, skin discolouration. Vivaglobin dosage: 60 ML Q1W SC; SC; SC; SC. During the same period patient was treated with ZANTAC. Patient recovered.

Vivaglobin Side Effects Report #5581314-9
Vivaglobin side effect was reported by a Health Professional from UNITED KINGDOM on Dec 14, 2007. Female patient, 46 years of age, was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: erysipelas, injection site erythema, injection site swelling. Vivaglobin dosage: 114 DAILY SC; 114 ML Q1W SC. Patient recovered.

Vivaglobin Side Effects Report #6012887-X
Vivaglobin side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Female patient, 15 years of age, weighting 119.0 lb, was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: complex regional pain syndrome , injection site swelling, monoparesis, skin discolouration. Vivaglobin dosage: 60 ML Q1W SC. During the same period patient was treated with ZANTAC. Patient recovered.